Established CVD risk factors account for 57 and 84 percent of the increased rate of CVD for preeclampsia, gestational HTN
MONDAY, May 9, 2022 (HealthDay News) — Women with hypertensive disorders of pregnancy (HDP) have an increased risk for cardiovascular disease (CVD) later in life, with most of the increased risk conferred by established CVD risk factors, according to a study published in the May 17 issue of the Journal of the American College of Cardiology.
Jennifer J. Stuart, Sc.D., from Brigham and Women’s Hospital and Harvard Medical School in Boston, and colleagues examined the associations between HDP and long-term CVD among 60,379 parous participants without CVD in the Nurses’ Health Study II.
The researchers found that compared with women with normotensive pregnancies, women with HDP in first pregnancy had a 63 percent higher rate of CVD. Established CVD risk factors mediated this association (proportion mediated, 64 percent). The increased CVD rate was higher for preeclampsia than gestational hypertension (hazard ratios, 1.72 and 1.41, respectively). Established CVD risk factors accounted for 57 and 84 percent of the increased rate of CVD for preeclampsia and gestational hypertension, respectively.
“Our findings suggest that screening for and treatment of chronic hypertension, hypercholesterolemia, type 2 diabetes mellitus, and overweight/obesity following a pregnancy may delay, or even prevent, cardiovascular disease among women with a history of HDP,” the authors write.
Higher Parental Vitamin B12 Tied to Lower Prevalence of Birth Defects
Paternal Exposure to Valproate Not Linked to Offspring Neurodevelopmental Disorders
Dose-Dependent Link Seen for Clomiphene Citrate, Adverse Perinatal Outcomes
Effect of Preparation Techniques Before Embryo Transfer Appears to Be Limited
Dietary Nitrate From Beetroot Juice Promising for Pregnant Women With CKD
Wildfires Now Top Source of Unhealthy Air for Pregnant Women in U.S.
Childhood Body Size Linked to Subsequent Reproductive Outcomes
Conditional Recommendations Developed for Obstructive Sleep Apnea in Pregnancy